Daily Stock Setups

Celsion to Hold Third Quarter 2009 Financial Results Conference Call Tuesday, November 10, 2009

Posted on: Fri, 06 Nov 2009 14:45:00 EST

Symbols: CLSN

Are you looking to increase your ETF knowledge?

COLUMBIA, Md., Nov 06, 2009 (BUSINESS WIRE) --
CLSN | Quote | Chart | News | PowerRating -- Celsion Corporation (NASDAQ:CLSN), a late stage clinical oncology
development company that is leveraging its heat activated liposomal
technology platform to encapsulate and deliver high concentrations of
proven chemotherapeutics, today announced that it will hold a conference
call to discuss third quarter 2009 results at 11:00 a.m. Eastern Time on
Tuesday, November 10, 2009. To participate in the call, interested
parties may dial 1-877-852-6580 or 1-719-325-4751 (International) and
use Conference ID: 2474093 to register ten minutes before the call is
scheduled to begin. The call will also be broadcast live on the internet
at http://www.celsion.com

The call will be archived for replay on November 10, 2009 at 2:00 p.m.
and will remain available until November 17, 2009. The replay can be
accessed at 1-888-203-1112 or 1-719-457-0820 (International) using
Conference ID: # 2474093. The call will also be available on the
Company's website, http://www.celsion.com,
for 30 days after 2:00 P.M. on Tuesday, November 10, 2009.

About Celsion Corporation

Celsion is dedicated to the development and commercialization of
innovative oncology drugs including tumor-targeting treatments using
focused heat energy in combination with heat-activated drug delivery
systems. Celsion has licensed ThermoDox(R) to Yakult-Honsha for
the Japanese market and has a partnership agreement with Phillips
Medical to jointly develop its heat activated liposomal technology in
combination with high intensity focused ultrasound to treat difficult
cancers. Celsion has research, license, or commercialization agreements
with leading institutions such as the National Institutes of Health,
Duke University Medical Center, University of Hong Kong, Cleveland
Clinic, and the North Shore Long Island Jewish Health System.

For more information on Celsion, visit our website: http://www.celsion.com

Celsion wishes to inform readers that forward-looking statements in
this release are made pursuant to the "safe harbor" provisions of the
Private Securities Litigation Reform Act of 1995. Readers are cautioned
that such forward-looking statements involve risks and uncertainties
including, without limitation, unforeseen changes in the course of
research and development activities and in clinical trials by others;
possible acquisitions of other technologies, assets or businesses;
possible actions by customers, suppliers, competitors, regulatory
authorities; and other risks detailed from time to time in the Company's
periodic reports filed with the Securities and Exchange Commission.

ThermoDox(R) is a registered trademark of
Celsion Corporation

SOURCE: Celsion Corporation


Celsion Corporation 
Sean Moran, 410-290-5390 
Senior Vice President and Chief Financial Officer 
smoran@celsion.com 
or 
The Trout Group 
Marcy Nanus, 646-378-2927 
mnanus@troutgroup.com

For full details on Celsion Corp (CLSN) CLSN. Celsion Corp (CLSN) has Short Term PowerRatings at TradingMarkets. Details on Celsion Corp (CLSN) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.